The Estrogen Receptor Agonists Market size is expected to surpass USD 9 billion by 2035, observing a CAGR of nearly 7% from 2023 to 2035. The industry size of Estrogen Receptor Agonists was USD 4 billion in 2022. This growth in market demand is expected to be driven by the increasing prevalence of cardiovascular diseases. According to the World Health Organization (WHO), cardiovascular diseases (CVDs) are the leading cause of death worldwide, accounting for approximately 17.9 million deaths annually. Hence, there is an increasing demand for various therapies to treat it, among which estrogen receptor agonists are the most preferred. It has also proven to be one of the safer treatments for cardiovascular diseases.
Postmenopausal women also commonly receive estrogen receptor agonist therapy because they experience a variety of consequences, including decreased ovarian function and decreased levels of sex steroid hormones in the blood. By 2030, the number of postmenopausal women worldwide is expected to reach 1.2 billion.
Growth drivers
Challenge
|
Base year |
2022 |
|
Forecast year |
2023-2035 |
|
CAGR |
~ 7 % |
|
Base Year Market Size (2022) |
~ US$4 billion |
|
Forecast Year Market Size (2035) |
~ USD 9 billion |
|
Area coverage |
|
Administrative route (oral parental)
The Estrogen Receptor Agonists Market in the Oral segment is expected to generate the highest revenue by the end of 2035. The growth of this segment is expected to increase due to its cost-effectiveness. Since parenteral drugs must be sterile and isotonic, oral drugs available in the market are cheaper, which can result in financial savings for patients. Also, oral drugs are absorbed at a faster rate. Hence, they are most preferred.
Distribution channels (hospital pharmacy retail pharmacy online pharmacy)
The hospital pharmacy segment of the estrogen receptor agonist market is expected to witness notable growth during the forecast period. Most of the estrogen receptor agonist drugs are prescribed by physicians. Therefore, hospital-affiliated pharmacies are expected to meet the growing demand for these drugs.
The in-depth analysis of the Estrogen Receptor Agonists Market includes the following segments:
|
Product Type |
|
|
Display type |
|
|
Administrative route |
|
|
Distribution Channels |
|
APAC Market Statistics
The Asia Pacific Estrogen Receptor Agonist Market is expected to witness the highest growth by the end of 2035, driven by the increasing geriatric population in the region. In Asia Pacific, one in four people is expected to be aged 60 or above by 2050. Moreover, this transition is expected to take place relatively quickly in several countries such as the People's Republic of China, Sri Lanka, Thailand, and Vietnam. This is expected to increase the demand for estrogen receptor agonists. Geriatric people are prone to various diseases such as cardiovascular diseases, asthma, etc. Therefore, the market is expected to grow to treat or prevent the growth of diseases.
North American Market Outlook
The North American Estrogen Receptor Agonist Market is expected to witness significant growth during the forecast period. The market in the region is poised to grow due to the increasing incidence of cancer.
저자 크레딧: Radhika Pawar
무료 샘플 사본에는 시장 개요, 성장 추세, 통계 차트 및 표, 예상 예측 등이 포함됩니다.
이 보고서를 주문하기 전에 질문이 있으십니까?